Cargando…
CNS-Sparing Histamine H(3) Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms
Among the histamine receptors, growing evidence points to the histamine H(3) receptor as a pharmacological candidate to counteract the autonomic neuropathy associated with diabetes. The study aimed to evaluate the effect of PF00868087 (also known as ZPL-868), a CNS-sparing histamine H(3) receptor an...
Autores principales: | Rosa, Arianna Carolina, Nardini, Patrizia, Sgambellone, Silvia, Gurrieri, Maura, Spampinato, Simona Federica, Dell’Accio, Alfonso, Chazot, Paul L, Obara, Ilona, Liu, Wai L, Pini, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961615/ https://www.ncbi.nlm.nih.gov/pubmed/35204685 http://dx.doi.org/10.3390/biom12020184 |
Ejemplares similares
-
Histamine, histamine receptors, and neuropathic pain relief
por: Obara, Ilona, et al.
Publicado: (2019) -
Effects of PARP-1 Deficiency and Histamine H(4) Receptor Inhibition in an Inflammatory Model of Lung Fibrosis in Mice
por: Durante, Mariaconcetta, et al.
Publicado: (2019) -
The Interplay between Histamine H(4) Receptor and the Kidney Function: The Lesson from H(4) Receptor Knockout Mice
por: Verta, Roberta, et al.
Publicado: (2021) -
Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in Mice
por: Alrashdi, Ibrahim, et al.
Publicado: (2022) -
PPARγ/mTOR signalling: striking the right balance in cartilage homeostasis
por: Dell'Accio, Francesco, et al.
Publicado: (2015)